
- Signals the introduction of the SOBRcheck™ student safety application to the industry’s 20,300+ senior leaders,
- Expected commercial launch of the devices in 2021.


TORONTO, ON and VANCOUVER, BC and ERIE, PA /April 12, 2021 / Liquid Avatar Technologies Inc. (CSE:LQID)(OTC PINK:TRWRF)(FRA:4T51) (“Liquid Avatar Technologies” or the “Company“,), a global blockchain, digital-identity and fintech solutions company, together with ImagineAR Inc. (IP) (IPNFF), an Augmented Reality platform company, are excited to announce that Oasis Digital Studios (“Oasis”) has partnered with Apex Comics Group to publish Mr. Right, a new multimedia project by legendary Marvel Entertainment and pop culture veterans Tom DeFalco, Ron Frenz, and Sal Buscema.
The program will consist of printed and digital comic books, digital avatars produced for the Liquid Avatar Mobile App and Marketplace, and AR enhanced NFT collectibles with Oasis. A sneak preview of the program will be made virtually on April 13th at the special presentation “NFTs Myths, Market, Media & Mania,” hosted by Liquid Avatar, ImagineAR and Oasis Digital Studios: https://hello.liquidavatar.com/oasis-webinar-registration.
The integrated campaign, expected to launch in early summer, will feature a series of limited-edition print and digital comic books, along with collector-enhanced NFTs, Liquid Avatar digital icons available in the Liquid Avatar Marketplace, and a fully immersive Augmented Reality multimedia program. A pre-sale waiting list is available for prospective purchasers and NFT collectors at the Oasis website: www.oasisdigitalstudios.com
Mr. Right is led by Tom DeFalco, who was Marvel’s 10th Editor-in-Chief. During his tenure, the company had the most successful fiscal and creative years in its entire eight-decade history. DeFalco was a driving force innovating the entire Marvel Universe with creative concepts used to this day in the Marvel Cinematic Universe. He also worked closely with the toy manufacturer Hasbro in the 1980s, heading the creative team that produced the backstory and dossiers that served as the basis for the relaunch of the phenomenally successful G.I. Joe toy line and animated television show.” DeFalco is the author of dozens of graphic novels and hundreds of comic-book stories, including The Amazing Spider-Man, Fantastic Four, Thor, Justice League of America, Archie, Scooby-Doo, and Dazzler, and with artist Ron Frenz created New Warriors and Spider-Girl.
DeFalco has personally created and developed over three dozen characters that have been licensed for television, toys, T-shirts, posters, trading cards and other merchandise, and has written Khan and The Phantom for Moonstone Books. In 1990, he won a Comic-Con International’s Inkpot Award, given to individuals for their contributions to the worlds of comics, science fiction/fantasy, film, television, animation, and fandom services.
For almost 40 years, renowned comic-book artist Ron Frenz has drawn some of the industry’s most iconic characters, including Spider-Man, Thor, Hulk, Captain America, Fantastic Four, Iron Man, She-Hulk, Silver Surfer, Green Lantern, Superman and, as previously mentioned, co-created New Warriors and Spider-Girl with Tom DeFalco. Frenz received the 2009 Nemo Award for Excellence in the Cartoon Arts.
Renowned artist, penciler and inker Sal Buscema has been a fixture in the comic-book industry for almost 60 years, primarily with Marvel, where he spent long runs as artist of The Avengers, The Defenders and The Incredible Hulk. Starting in the industry shortly after graduating high school in 1955, Buscema went on to work in a number of ventures, including the military as an illustrator and later with his brother, famed comic-book artist, John Buscema. With industry credits too long to list, he penciled and mostly inked a 100-issue run on The Spectacular Spider-Man from from 1988 to 1996, Buscema’s DC Comics artwork contributions include Action Comics, Batman, Catwoman, Detective Comics, Green Arrow, Superboy, Superman and Wonder Woman, among others. For Marvel, his contributions include The Amazing Spider-Man, The Avengers, Battlestar Galactica, Captain America, Daredevil, Doctor Strange, Ghost Rider, Iron Man, Master of Kung Fu, Silver Surfer, She-Hulk, Rom, Thor, X-Men, and many others. Buscema has collaborated on numerous occasions with both Frenz and DeFalco.
Buscema received the Inkpot Award in 2003 and the Hero Initiative Lifetime Achievement Award in September 2013 at the Baltimore Comic-Con. In 2013, he received the Inkwell Award‘s S.P.A.M.I. (Favorite Small Press and Mainstream-Independent) Award for his work on such titles as G.I. Joe Annual and Dungeons and Dragons: Forgotten Realms. In 2018, he was awarded the Inkwell Awards’ S.P.A.M.I. Award again, for his work on Rom.
“Apex Comics Group is incredibly fortunate to have Tom, Ron and Sal aboard to helm the creative direction for Mr. Right. As a lifelong fan of their work, I can’t wait for the world to see the new adventures they have dreamed up!” – Mariano Nicieza, Apex Comics Group President
Non-Fungible Tokens (NFT) are digital assets that represent a wide range of unique tangible and intangible items, from art, comic books and collectible sports cards to virtual real estate and even digital sneakers. One of the main benefits of owning a digital collectible versus a physical collectible like a rookie card or a rare-minted coin is that each NFT contains distinguishing information that makes it both distinct from any other NFT and easily verifiable. This makes the creation and circulation of fake collectibles pointless because each item can be traced back to the original issuer.
Mr. Right
Mr. Right is the world’s first NFT super-athlete. Witness the thrill-packed origin of this digital daredevil as he takes on the savage hordes of Big Brother. PLUS, in a bonus story: When video gamer Jeffery “Player One” Lopez’s detective mother is attacked by the Dead Presidents Gang, he turns to the one man who can bring her assailants to justice – Mr. Right, the new champion of split-second action!
“Ron, Sal and I are thrilled to be partnered with Liquid Avatar, Oasis Digital Studios and Apex Comics. NFTs, digital icons and comics are all poised to break new ground in the craft of visual storytelling, and we can’t wait to see what the future holds for all of us. Hoo-Ha and thanks for joining us!” – Tom DeFalco
The Oasis AR Enhanced NFT experience will be available exclusively through the Liquid Avatar Mobile App, which allows the user to create digital icons to manage, control and create value from their biometrically verified digital identity.It is available in the Google Play and Apple App stores.
If you would like to join our mailing list and receive updates from the Company., please click here
Read More: https://agoracom.com/ir/LiquidAvatar/forums/discussion/topics/758893-oasis-digital-studios-and-apex-comics-group-partner-with-comic-book-industry-legends-for-new-multimedia-experiences-and-nfts/messages/2311629#message

St-Georges Eco-Mining Corp. (CNSX:SX.CN)(OTC:SXOOF) (FSE:85G1) is pleased to disclose the results of its initial electric vehicle (EV) cathode material battery recycling tests aimed at specific car makers and OEM battery specifications.
As previously disclosed in a press release titled “Initial Recovery Battery Test Results” dated February 22, 2021, the Company has set aside a significant portion of its laboratories resources to be able to perform “(…) additional tests to optimize the process of recovery of critical elements (…) using synthetic compounds to move the development along faster.” In a subsequent press release titled “EV Batteries Recovery Tests Results: Lithium” dated March 18, 2021, the Company disclosed that it had “(…) completed EV battery characterization for the following car makers: Tesla, General Motors (GM), Ford, Toyota, and Nissan. The batteries were sourced from industry aggregators. The Company’s chemists and metallurgists created synthetic powder clones of the metal’s components allowing the testing’s acceleration (…)” Additionally, leveraging the support of some important stakeholders in the success of Company initiatives, St-Georges’ metallurgists were able to gather data on the composition of certain batteries in development or about-to-be commercially deployed in the coming year that are Lithium-Iron-Phosphate or LFP (LiFePO4) based. These not-yet-on-the-market batteries have been conceptually characterized, synthetically reproduced, and tested with the Company’s processing technology.
Four sets of battery category, covering all current car makers previously mentioned, along with the addition of the LFP batteries, have been processed in St-Georges’ contracted pilot-plant installations:
----------------------------------------- |Main Core Powder|Chemical Formula | |---------------------------------------| |LCO |LiCoO2 | |---------------------------------------| |LMO |LiMn2O4 | |---------------------------------------| |NMC |LiNi0.33Mn0.33Co0.33O2| |---------------------------------------| |LFP |LiFePO4 | -----------------------------------------
Cathode materials results
This initial test campaign’s objective was to determine which metals were put in solution from cathode materials using St-Georges’ proprietary acid-blend. From those experiments, it can be deduced that Lithium, Iron, Phosphate, Cobalt, Nickel, and Magnesium can be expected to be found in solution when using commercial batteries, on top of other metals such as Aluminium, Manganese, and Copper that can be recuperated in situ.
It is important to note that the LFP batteries might require a slightly different process to recycle 100% of the metals. Iron content generates a small amount of magnetism during the process while everything else remains in line with other battery compounds.
| Click Here to Access Report: Stansberry Gold and Silver Investor |
![]() |
You can find us on twitter and Linked In
Find out more at www.americancreek.com
Thoughtful Brands, Inc. (CSE:TBI)(FWB:1WZ1)(OTCQB:PEMTF) (the “Company” or “Thoughtful Brands“), an eCommerce technology company that researches, develops, markets, and distributes natural health products through various brands in North America and Europe, announces that it intends to consolidate its issued and outstanding common shares (“Shares“) at a ratio of ten (10) pre-consolidated Shares to one (1) post-consolidation Share (the “Consolidation“).
The Company currently has 389,274,701 Shares issued and outstanding. Following the Consolidation there will be approximately 38,927,470 Shares issued and outstanding. No fractional Shares will be issued and any fractions of a Share will be rounded down to the nearest whole number of Shares. The exercise or conversion price and the number of Shares issuable under any of the Company’s outstanding convertible securities will be proportionately adjusted upon Consolidation.
In accordance with the Company’s Articles, the Consolidation will not require the approval of the shareholders.
The Consolidation is subject to the acceptance of the Canadian Securities Exchange.
About Thoughtful Brands Inc.
Thoughtful Brands Inc. is an eCommerce technology company that researches, develops, markets and distributes natural health products through various brands in North America and Europe.
ON BEHALF OF THE BOARD OF DIRECTORS
Thoughtful Brands Inc.
Ryan Hoggan
For further information readers are encouraged to contact Joel Shacker, President at +1604-423-4733.

Harborside Inc. (“Harborside” or the “Company”) (CSE: HBOR),(OTCQX: HBORF) a California-focused, vertically integrated cannabis enterprise, today announced Matt Hawkins, Chairman of the Board, and Peter Bilodeau, Interim CEO, will participate in the upcoming PI Financial Golden State Green: Going Deep Intro the California Cannabis Market Conference on Wednesday, April 14, 2021. Management is scheduled to present a Company overview at 12:50 p.m. ET. To register for the event, click here.
About Harborside:
Harborside Inc. is one of the oldest and most respected cannabis retailers in California, operating three of the major dispensaries in the San Francisco Bay Area, a dispensary in the Palm Springs area outfitted with Southern California’s only cannabis drive-thru window, a dispensary in Oregon and a cultivation/production facility in Salinas, California. Harborside has played an instrumental role in making cannabis safe and accessible to a broad and diverse community of California consumers. In 2006, Harborside was awarded one of the first six medical cannabis licenses granted in the United States and today holds cannabis licenses for retail, distribution, cultivation, nursery and manufacturing. Harborside is currently a publicly listed company on the Canadian Securities Exchange (“CSE”) trading under the ticker symbol “HBOR”. Additional information regarding Harborside is available under Harborside’s SEDAR profile at www.sedar.com.

VANCOUVER, BC , April 12, 2021 /PRNewswire/ – Maitri Health Technologies Corp. (” Maitri “) (CSE: MTEC) (FRA: D84), a global platform for healthcare supply security, today announced Andrew McCann, a digital innovator in cloud platforms and online user experiences, is joining as Chief Technology Officer (CTO).
Mr. McCann was a co-founder of DeviantArt, one of the first social media networks, and served as CTO until the company was acquired by Wix.com Ltd. (NASDAQ: WIX). During tenure as CTO, DeviantArt was a Hollywood -based online platform with over 40-million users and the world’s largest catalog of user created online images. At it’s peak, DeviantArt handled traffic of over two billion page views per month, requiring incredibly sophisticated data management and development.
Mr. McCann’s entrepreneurial innovations began earlier, when he co-founded Silicon Valley-based MediaScience Inc., acquired by Lycos, now part of Brightcom Group Ltd. (NSE: BCM), and built Sonique, one of the world’s first, and eventually second biggest, desktop audio players.
Mr. McCann has advised to health-tech companies, AI start-ups and does mentoring work with Creative Destruction Labs.

VANCOUVER, BC , April 12, 2021 – PlantX Life Inc. (CSE: VEGA ) (Frankfurt: WNT1) (OTCQB: PLTXF) (“PlantX” or the “Company”) is pleased to announce that it achieved record monthly gross revenue of $1,565,982 for March 2021 and a revenue of $1,353,613 for February 2021 . Cost of Goods Sold were $1,152,276 and $994,260 for March and February, respectively.
PlantX continues to experience month-over-month revenue increases, as shown by the financial results in recent months. For the month of March 2021 , the Company achieved a new record gross revenue of $1,565,982 , reflecting a 15.6% increase from February 2021 and a 43.7% increase from January 2021 . These accomplishments are a reflection of the Company’s dynamic expansion and its unwavering commitment to delivering the best quality products and services to its loyal customer base. The monthly revenue increase also builds confidence in PlantX’s capabilities to continue on a growth trajectory for the rest of 2021.
“The Company’s progress is a manifestation of its results-driven strategy to capitalize on high-growth verticals, create strategic partnerships and expand globally,” said PlantX CEO, Julia Frank . “PlantX continues to add value as a leader in the plant-based industry.”
“The recent revenue growth is a strong indicator that we are consistently building great momentum in our quest to thrive as a business,” said PlantX Founder, Sean Dollinger . “Our financial progress continues to accelerate month after month, and we have no intention of slowing down.”
The financial results disclosed in this press release are management prepared and have not been audited or reviewed by the Company’s auditors. Unless otherwise indicated, all amounts are expressed in Canadian dollars.
About PlantX Life Inc.
As the digital face of the plant-based community, PlantX’s platform is the one-stop shop for everything plant-based. With its fast-growing category verticals, the Company offers customers across North America more than 10,000 plant-based products. In addition to offering meal and indoor plant deliveries, the Company currently has plans underway to expand its product lines to include cosmetics, clothing and its own water brand — but the business is not limited to an e-commerce platform. The Company uses its digital platform to build a community of likeminded consumers and, most importantly, provide education. Its successful enterprise is being built and fortified on partnerships with top nutritionists, chefs and brands. The Company eliminates the barriers to entry for anyone interested in living a plant-based lifestyle and thriving in a longer, healthier and happier life.
The Company website is http://investor.PlantX.com/ .
To visit the Company’s YouTube channel , click here .
You can tune in to PlantX’s live vodcast tonight at 8PM EST to watch a discussion between the PlantX Founder and the and PlantX CFO. To view the show, click here .
Read More: https://agoracom.com/ir/PlantX/forums/discussion/topics/758869-plantx-announces-monthly-gross-revenues-of-1-565-982-for-march-2021-and-1-353-613-for-february-2021/messages/2311569#message

Prof. Hania Szajewska will lead the Company’s clinical studies in Europe . Dr. Carina Venter will lead key studies in the U.S.

VANCOUVER, BC , April 12, 2021 ELSE NUTRITION HOLDINGS INC. (TSXV: BABY ) (OTCQX: BABYF ) (FSE: 0YL ) (“Else” or the “Company”) the Plant-Based baby, toddler and children nutrition company , is pleased to announce the addition of 2 world-class experts to its Scientific Advisory Board.
“The importance of these 2 new Advisory Board members cannot be understated. Prof. Szajewska and Dr. Venter bring immense and invaluable expertise which significantly bolsters our pathway toward commercializing clean label, plant-based infant nutrition in both the U.S. and European markets,” said Hamutal Yitzhak , Else CEO & Co-Founder.
Professor Hania Szajewska , MD, is Professor and Chair of the Department of Pediatrics at the Medical University of Warsaw . Until June 2019 , she served as the Editor-in-Chief of the Journal of Pediatric Gastroenterology and Nutrition . Previously, Prof. Szajewska served as a member of the Council and then as the General Secretary of the European Society for Pediatric Gastroenterology, Hepatology and Nutrition (ESPGHAN). She also served as the Secretary of the ESPGHAN Committee on Nutrition. Most recently ( January 2019 ), she joined the Board of Directors of the International Scientific Association for Probiotics and Prebiotics. She has co-authored more than 320 publications. In 2020, Prof. Szajewska has been ranked as one of the world’s top 2% most-cited researchers. She will lead Else’s clinical studies in Europe .
Dr. Carina Venter obtained her PhD from the University of Southampton. She moved from the UK in 2015 where she had been performing research into food allergies and allergy prevention as a Senior Lecturer at the University of Portsmouth at the David Hide Centre on the Isle of Wight. Dr. Venter (PhD RD) is currently an Associate Professor of Pediatrics, Section of Allergy/Immunology at the Children’s Hospital Colorado and University of Colorado Denver , where she is conducting research in allergy prevention and working with children with food allergies. She is a member of American, European, and British Allergy Societies. She is a member of European and American food allergy guidelines on Allergy Prevention. She was also a member of the NICE (UK) and National Institutes for Allergy and Infectious Diseases Food Allergy guidelines. She will lead Else’s hypoallergenicity studies in the U.S.
About Else Nutrition Holdings Inc.
Else Nutrition GH Ltd. is an Israel -based food and nutrition company focused on developing innovative, clean and plant-based food and nutrition products for infants, toddlers, children, and adults. Its revolutionary, plant-based, non-soy, formula is a clean-ingredient alternative to dairy-based formula. Else Nutrition (formerly INDI) won the “2017 Best Health and Diet Solutions” award at the Global Food Innovation Summit in Milan . Else Plant-Based Complete Nutrition for Toddlers was recently ranked as the #1 Top seller in the baby and toddler formula category on Amazon. The holding company, Else Nutrition Holdings Inc., is a publicly traded company, listed as TSX Venture Exchange under the trading symbol BABY and is quoted on the US OTC Markets QX board under the trading symbol BABYF and on the Frankfurt Exchange under the symbol 0YL. Else’s Executives includes leaders hailing from leading infant nutrition companies. Many of Else advisory board members had past executive roles in companies such as Mead Johnson, Abbott Nutrition, Plum Organics and leading infant nutrition Societies, and some of them currently serve in different roles in leading medical centers and academic institutes such as Boston Children’s Hospital, Pediatrics at Harvard Medical School , USA , Tel Aviv University , Schneider Children’s Medical Center of Israel , Rambam Medical Center and Technion, Israel and University Hospital Brussels, Belgium .
Read More: https://agoracom.com/ir/ElseNutritionHoldings/forums/discussion/topics/758858-globally-acclaimed-pediatrics-nutrition-and-allergies-experts-join-else-s-advisory-board/messages/2311556#message